Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2024 · Molecular Cancer Therapeutics · 5 citations
https://doi.org/10.1158/1535-7163.mct-23-0733
R
Ruben J.L. van Ardenne
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
5
Citations
1
h-index
0
i10-index
Ruben J.L. van Ardenne is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune cells in cancer & Immune Cell Function and Interaction. The author has an h-index of 1, co-authored 8 publications.
ORCID: 0009-0005-5523-5821Papers by this author
worksSupplementary Fig. 4 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025 · 0 citations
https://doi.org/10.1158/1535-7163.28713935
Supplementary Fig. 5 from Combination of Bremachlorin PDT and Immune Checkpoint Inhibitor Anti–PD-1 Shows Response in Murine Immunological T-cell–High and T-cell–Low PDAC Models
2025 · 0 citations
https://doi.org/10.1158/1535-7163.28713932
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat